- Home
- EVLVW vs KLTOW Comparison
EVLVW vs KLTOW Comparison
Compare EVLVW & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVLVW
- KLTOW
- Stock Information
- Founded
- EVLVW 2013
- KLTOW N/A
- Country
- EVLVW United States
- KLTOW United States
- Employees
- EVLVW 287
- KLTOW 3
- Industry
- EVLVW Computer peripheral equipment
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVLVW Technology
- KLTOW Health Care
- Exchange
- EVLVW Nasdaq
- KLTOW Nasdaq
- Market Cap
- EVLVW N/A
- KLTOW N/A
- IPO Year
- EVLVW N/A
- KLTOW 2022
- Fundamental
- Price
- EVLVW $0.53
- KLTOW $0.17
- Analyst Decision
- EVLVW
- KLTOW
- Analyst Count
- EVLVW 0
- KLTOW 0
- Target Price
- EVLVW N/A
- KLTOW N/A
- AVG Volume (30 Days)
- EVLVW 17.7K
- KLTOW N/A
- Earning Date
- EVLVW 02-28-2025
- KLTOW N/A
- Dividend Yield
- EVLVW N/A
- KLTOW N/A
- EPS Growth
- EVLVW N/A
- KLTOW N/A
- EPS
- EVLVW N/A
- KLTOW N/A
- Revenue
- EVLVW $89,220,000.00
- KLTOW N/A
- Revenue This Year
- EVLVW N/A
- KLTOW N/A
- Revenue Next Year
- EVLVW N/A
- KLTOW N/A
- P/E Ratio
- EVLVW N/A
- KLTOW N/A
- Revenue Growth
- EVLVW 17.67
- KLTOW N/A
- 52 Week Low
- EVLVW $0.28
- KLTOW N/A
- 52 Week High
- EVLVW $0.34
- KLTOW N/A
- Technical
- Relative Strength Index (RSI)
- EVLVW 37.18
- KLTOW 50.51
- Support Level
- EVLVW $0.55
- KLTOW $0.15
- Resistance Level
- EVLVW $0.82
- KLTOW $0.17
- Average True Range (ATR)
- EVLVW 0.10
- KLTOW 0.02
- MACD
- EVLVW -0.02
- KLTOW -0.00
- Stochastic Oscillator
- EVLVW 0.00
- KLTOW 42.70
About EVLVW Evolv Technologies Holdings Inc.
Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.